Newsroom

SAINT-PRIEST, France--(BUSINESS WIRE)--Regulatory News: Jacquet Metals SA (Paris:JCQ) : Date Nombre d'actions composant le capital Nombre de droits de vote théoriques 31 mai 2026 21 531 967 31 277 192 Le nombre total des droits de vote exerçables attachés à ces 21 531 967 actions s’élève à 30 037 527 droits de vote en tenant compte des 1 239 665 actions autodétenues par JACQUET METALS SA et privées de droits de vote en vertu des articles L.225-111 et L.225-210 du Code de commerce....

PAU, France--(BUSINESS WIRE)--Regulatory News: Arverne (FR001400JWR8 - ARVEN), 1er fournisseur français de solutions géothermales, publie l’information relative au nombre total des droits de vote et au nombre d’actions composant son capital social au 8 juin 2026, conformément aux dispositions de l’article R. 22-10-23 du Code de commerce. Date Nombre d’actions composant le capital Nombre total de droits de vote 8 juin 2026 42 076 081 Nombre de droits de vote théoriques* : 65 229 659 Nombre de dr...

PAU, France--(BUSINESS WIRE)--Regulatory News: Arverne (FR001400JWR8 - ARVEN), the leading French supplier of geothermal solutions, publishes information relating to the total number of voting rights and the number of shares in its share capital at June 10, 2026, in accordance with the provisions of article R. 22-10-23 of the French Commercial Code. Date Total number of shares in the capital Total number of voting rights June 8, 2026 42 076 081 Number of theoretical voting rights: 65 229 659 Nu...

LYON, France--(BUSINESS WIRE)--Regulatory News: Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical company focused on the research and development of innovative therapeutic solutions for the treatment of diabetes and obesity, confirms that it meets the eligibility criteria for its shares to be held in a PEA-PME account, set forth in Article L.221-32-2 of the French Monetary and Financial Code. Consequently, investment in Adocia shares can be made through PEA-PME sa...

EL SEGUNDO, Calif. & TOKYO--(BUSINESS WIRE)--HARIO will debut two new V60 Dripper NEO colors on June 25, with their first showcase set for World of Coffee Brussels 2026....

LYON, France--(BUSINESS WIRE)--Regulatory News : Adocia (Euronext Paris : FR0011184241 – ADOC), société biopharmaceutique au stade clinique spécialisée dans la recherche et le développement de solutions thérapeutiques innovantes pour le traitement du diabète et de l’obésité, confirme respecter les critères d’éligibilité au dispositif PEA-PME fixés par l’article L.221‑32‑2 du Code monétaire et financier. En conséquence, les actions Adocia peuvent pleinement être intégrées au sein des comptes PEA...

TOKYO--(BUSINESS WIRE)--OKI (TOKYO:6703) has been selected as the representative organization for the technology development project titled “Development and Global Deployment of a Next-Generation Infrastructure Monitoring System Through Close Integration of Satellites and Ground Sensors,” proposed jointly with LTS, Inc. (Head office: Minato-ku, Tokyo; President and Representative Director: Hiroaki Kabashima; “LTS”). The project comes under the technology development theme “Acceleration of Imple...

SAINT-PRIEST, France--(BUSINESS WIRE)--Regulatory News: Jacquet Metals SA (Paris:JCQ): Date Total number of shares Number of theoretical voting rights May 31, 2026 21 531 967 31 277 192 The total number of exercisable voting rights attached to these 21 531 967 shares is 30 037 527, taking into account the 1 239 665 treasury shares held by JACQUET METALS SA and stripped of voting rights under Articles L.225-111 and L.225-210 of the French Commercial Code....

SALT LAKE CITY & PALM BEACH, Fla. & PALO ALTO, Calif.--(BUSINESS WIRE)--Crewe Advisors LLC (“Crewe”), a Utah-based registered investment adviser (“RIA”), today announced it will enter into a strategic partnership with Wealth Partners Capital Group (“WPCG”), a financial services holding company, and HGGC, a values-driven, partnership-focused middle-market private equity firm. WPCG and the Aspire Holdings platform of HGGC will make a minority equity investment in Crewe to support the firm’s growt...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sumitomo Pharma America, Inc. (SMPA) today announced that it has enrolled the required number of participants in its pivotal Phase 2 monotherapy trial for enzomenib, an investigational, oral selective menin inhibitor for the treatment of relapsed/refractory acute leukemia with KMT2A rearrangement, to allow for interim analysis. Achieving this milestone will enable SMPA to obtain results of the interim analysis by the end of calendar year 2026. These results...